Treatment of Mucosal Bolivian Leishmaniasis
Condition: Mucosal Leishmaniasis Interventions: Drug: Group 1: Miltefosine; Drug: Group 2: Pentavalent Antimony; Drug: Group 3: Liposomal amphotericin B Sponsors: Fundacion Nacional de Dermatologia; Hospital Dermatologico de Jorochito; Centro Nacional de Enfermedades Tropicales CENETROP; ABF Foundation for Medical Research Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials